JORGE CASTILLO to Lymphoma
This is a "connection" page, showing publications JORGE CASTILLO has written about Lymphoma.
Connection Strength
1.982
-
Prognostic value of disease risk score versus gait speed in older adults with lymphoma. Leuk Lymphoma. 2021 12; 62(12):2882-2889.
Score: 0.586
-
Viral lymphomagenesis: beyond the usual suspects. Br J Haematol. 2018 09; 182(5):617-618.
Score: 0.475
-
Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies. Br J Haematol. 2014 May; 165(3):300-15.
Score: 0.353
-
An international, multicenter, retrospective study on the positive impact of cutaneous involvement on the clinical outcome of adult T-cell leukemia/lymphoma. Leuk Lymphoma. 2022 02; 63(2):315-325.
Score: 0.150
-
Real-World Data on Adult T-Cell Leukemia/Lymphoma in Latin America: A Study From the Grupo de Estudio Latinoamericano de Linfoproliferativos. JCO Glob Oncol. 2021 07; 7:1151-1166.
Score: 0.147
-
EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol. 2016 May; 91(5):529-37.
Score: 0.103
-
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis. Blood. 2014 Oct 09; 124(15):2354-61.
Score: 0.092
-
CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies. Expert Opin Investig Drugs. 2012 Jan; 21(1):15-22.
Score: 0.076